Výsledky vyhledávání - "ALVERTOS SOMARAKIS"

Akademický článek

Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)

Autor: Michalis Liontos, Eleni Timotheadou, Emmanuel I. Papadopoulos, Zafeiris Zafeiriou, Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos, Dimitrios Mavroudis, Christos Christodoulou, Adamantia Nikolaidi, Alvertos Somarakis, Christos Papadimitriou, Christos Papandreou, Aristotelis Bamias

Publikováno v: Current Oncology, Vol 28, Iss 6, Pp 5266-5277 (2021)

New treatment modalities have been recently introduced in the management of ovarian cancer (OC). Herein, we sought to investigate their implementation in routine clinical practice and examine the real-world management of OC in Greece. EpOCa was a non

Externí odkaz: https://doaj.org/article/eae8a53963424f27a35cc8b6f95afa6a

Zobrazit plný text záznamu

Clinical Outcomes Beyond 1LEGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’

Publikováno v: Anticancer Research. 43:2243-2258

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c90b5852878ba243baf4ce721d544c5c
https://doi.org/10.21873/anticanres.16388

Zobrazit plný text záznamu

Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece

Autor: Sofia Lampaki, Giannis Mountzios, Vassilis Georgoulias, Aggeliki Rapti, Ioannis Xanthakis, Sofia Baka, Dimitrios Mavroudis, Epaminondas Samantas, Elias Athanasiadis, Flora Zagouri, Andriani Charpidou, Alvertos Somarakis, Christina Papista, Aristeidis Nikolaou, Eleftheria Anastasopoulou, Zoe Paparepa, Konstantinos N Syrigos

Publikováno v: Future Oncology. 18:3151-3164

Aim: To retrospectively characterize real-world therapeutic strategies, clinical outcomes and attrition rates with EGFR tyrosine kinase inhibitors (TKIs), before first-line osimertinib approval, in EGFR-mutated advanced/metastatic non-small-cell lung

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbb4e294a6459568630b3518a5e5d2b1
https://doi.org/10.2217/fon-2022-0386

Zobrazit plný text záznamu

A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The ‘LUNGFUL’ Study

Autor: Anna Koumarianou, Giannis Mountzios, Sofia Lampaki, Alexandros Bokas, Aristeidis Nikolaou, Helena Linardou, Konstantinos N. Syrigos, Epaminondas Samantas, Michalis V. Karamouzis, George Pentheroudakis, Elias Athanasiadis, Zoe Paparepa, Dimitrios Mavroudis, Alvertos Somarakis, Marios Froudarakis, Panagiotis Katsaounis, Eleni-Isidora A. Perdikouri, Foteini Papageorgiou, Evangelos Georgios Fergadis

Publikováno v: Cancers, Vol 13, Iss 3172, p 3172 (2021)
Cancers
Volume 13
Issue 13

Simple Summary Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, with few patients carrying driver mutations in the gene encoding for epidermal growth factor receptor (EGFR). Advances in translational research ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79937ccf52412189b7954b30b4236e33
https://www.mdpi.com/2072-6694/13/13/3172

Zobrazit plný text záznamu

A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First or Second Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer: The ‘LUNGFUL’ Study

Autor: Helena Linardou, Epaminondas Samantas, Elias Athanasiadis, Alexandros Bokas, Marios Froudarakis, Sofia Lampaki, Foteini Papageorgiou, Anna Koumarianou, George Pentheroudakis, Michalis V. Karamouzis, Eleni-Isidora A. Perdikouri, Giannis Mountzios, Dimitrios Mavroudis, Alvertos Somarakis, Aristeidis Nikolaou, Evangelos Georgios Fergadis, Panagiotis Katsaounis, Zoe Paparepa, Konstantinos N. Syrigos

Background: Real-world data on the molecular epidemiology of EGFR resistance mutations at or after progression with first- or second-generation EGFR-TKIs in patients with advanced NSCLC are lacking. Methods: This ongoing observational study was carri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ae3a8c3c3cb7d3fe4854e1ac111038

Zobrazit plný text záznamu

Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)

Autor: Michalis Liontos Eleni Timotheadou Emmanuel I. Papadopoulos Zafeiris Zafeiriou Dimitra Ioanna Lampropoulou Gerasimos Aravantinos Dimitrios Mavroudis Christos Christodoulou Adamantia Nikolaidi Alvertos Somarakis Christos Papadimitriou Christos Papandreou Aristotelis Bamias

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::ee7492b203aaad8432b753dff10ae6d6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2970232

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání